{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:09:43Z","timestamp":1793106583254,"version":"4.5.0"},"reference-count":142,"publisher":"BMJ","issue":"7","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23NS089922"],"award-info":[{"award-number":["K23NS089922"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 NS108022"],"award-info":[{"award-number":["R21 NS108022"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R34AG056639"],"award-info":[{"award-number":["R34AG056639"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1RR024992 Sub-Award KL2TR000450,"],"award-info":[{"award-number":["UL1RR024992 Sub-Award KL2TR000450,"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR000448"],"award-info":[{"award-number":["UL1TR000448"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2020,4,17]]},"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:p>The rapid eye movement sleep behavioural disorder (RBD) population is an ideal study population for testing disease-modifying treatments for synucleinopathies, since RBD represents an early prodromal stage of synucleinopathy when neuropathology may be more responsive to treatment. While clonazepam and melatonin are most commonly used as symptomatic treatments for RBD, clinical trials of symptomatic treatments are also needed to identify evidence-based treatments. A comprehensive framework for both disease-modifying and symptomatic treatment trials in RBD is described, including potential treatments in the pipeline, cost-effective participant recruitment and selection, study design, outcomes and dissemination of results. For disease-modifying treatment clinical trials, the recommended primary outcome is phenoconversion to an overt synucleinopathy, and stratification features should be used to select a study population at high risk of phenoconversion, to enable more rapid clinical trials. For symptomatic treatment clinical trials, objective polysomnogram-based measurement of RBD-related movements and vocalisations should be the primary outcome measure, rather than subjective scales or diaries. Mobile technology to enable objective measurement of RBD episodes in the ambulatory setting, and advances in imaging, biofluid, tissue, and neurophysiological biomarkers of synucleinopathies, will enable more efficient clinical trials but are still in development. Increasing awareness of RBD among the general public and medical community coupled with timely diagnosis of these diseases will facilitate progress in the development of therapeutics for RBD and associated neurodegenerative disorders.<\/jats:p>","DOI":"10.1136\/jnnp-2020-322875","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T17:30:34Z","timestamp":1589391034000},"page":"740-749","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":85,"title":["Clinical trials in REM sleep behavioural disorder: challenges and opportunities"],"prefix":"10.1136","volume":"91","clinical-trial-number":[{"clinical-trial-number":"nct02462603","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9237-1516","authenticated-orcid":false,"given":"Aleksandar","family":"Videnovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yo-El S","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Arnulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6460-4319","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Cochen-De Cock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"H\u00f6gl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Provini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro-Luca","family":"Ratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mya C","family":"Schiess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos H","family":"Schenck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Trenkwalder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"key":"2024111108300550000_91.7.740.1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nrneurol.2017.157","article-title":"Idiopathic REM sleep behaviour disorder and neurodegeneration - an update","volume":"14","author":"H\u00f6gl","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"2024111108300550000_91.7.740.2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz030"},{"key":"2024111108300550000_91.7.740.3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.sleep.2013.02.016","article-title":"Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy\u2014a consensus statement from the International rapid eye movement sleep behavior disorder Study Group","volume":"14","author":"Schenck","year":"2013","journal-title":"Sleep Med"},{"key":"2024111108300550000_91.7.740.4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.smrv.2016.11.002","article-title":"Idiopathic REM sleep behavior disorder and neurodegenerative risk: to tell or not to tell to the patient? How to minimize the risk?","volume":"36","author":"Arnaldi","year":"2017","journal-title":"Sleep Med Rev"},{"key":"2024111108300550000_91.7.740.5","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ncl.2005.06.002","article-title":"Rapid eye movement sleep Parasomnias","volume":"23","author":"Schenck","year":"2005","journal-title":"Neurol Clin"},{"key":"2024111108300550000_91.7.740.6","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/acn3.630","article-title":"Alcohol consumption and probable rapid eye movement sleep behavior disorder","volume":"5","author":"Ma","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"2024111108300550000_91.7.740.7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5664\/jcsm.27717","article-title":"Best practice guide for the treatment of REM sleep behavior disorder (RBD)","volume":"6","author":"Aurora","year":"2010","journal-title":"J Clin Sleep Med"},{"key":"2024111108300550000_91.7.740.8","doi-asserted-by":"crossref","first-page":"114-20","DOI":"10.1016\/j.sleep.2015.12.020","article-title":"A prospective, naturalistic follow-up study of treatment outcomes with clonazepam in rapid eye movement sleep behavior disorder","volume":"21","author":"Li","year":"2016","journal-title":"Sleep Med"},{"key":"2024111108300550000_91.7.740.9","doi-asserted-by":"crossref","first-page":"224-231","DOI":"10.1111\/j.1365-2869.1993.tb00093.x","article-title":"Symposium: normal and abnormal REM sleep regulation: REM sleep behaviour disorder: an update on a series of 96 patients and a review of the world literature","volume":"2","author":"Schenck","year":"1993","journal-title":"J Sleep Res"},{"key":"2024111108300550000_91.7.740.10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/brain\/123.2.331","article-title":"Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases","volume":"123 (Pt 2)","author":"Olson","year":"2000","journal-title":"Brain"},{"key":"2024111108300550000_91.7.740.11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5665\/sleep.5332","article-title":"The clinical phenotype of idiopathic rapid eye movement sleep behavior disorder at presentation: a study in 203 consecutive patients","volume":"39","author":"Fern\u00e1ndez-Arcos","year":"2016","journal-title":"Sleep"},{"key":"2024111108300550000_91.7.740.12","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H587"},{"key":"2024111108300550000_91.7.740.13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5664\/jcsm.27492","article-title":"Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam","volume":"5","author":"Anderson","year":"2009","journal-title":"J Clin Sleep Med"},{"key":"2024111108300550000_91.7.740.14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jns.2019.04.029","article-title":"Clonazepam for probable REM sleep behavior disorder in Parkinson's disease: a randomized placebo-controlled trial","volume":"401","author":"Shin","year":"2019","journal-title":"J Neurol Sci"},{"key":"2024111108300550000_91.7.740.15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.sleep.2012.09.018","article-title":"Treatment outcomes in REM sleep behavior disorder","volume":"14","author":"McCarter","year":"2013","journal-title":"Sleep Med"},{"key":"2024111108300550000_91.7.740.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2014.09.011"},{"key":"2024111108300550000_91.7.740.17","doi-asserted-by":"publisher","DOI":"10.1016\/S1389-9457(03)00072-8"},{"key":"2024111108300550000_91.7.740.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2869.2010.00848.x"},{"key":"2024111108300550000_91.7.740.19","doi-asserted-by":"publisher","DOI":"10.1159\/000119383"},{"key":"2024111108300550000_91.7.740.20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/acn3.753","article-title":"Prolonged-release melatonin in patients with idiopathic REM sleep behavior disorder","volume":"6","author":"Jun","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"2024111108300550000_91.7.740.21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jamaneurol.2013.6239","article-title":"Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease","volume":"71","author":"Videnovic","year":"2014","journal-title":"JAMA Neurol"},{"key":"2024111108300550000_91.7.740.22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/jamaneurol.2014.65","article-title":"Sleep and circadian rhythm regulation in early Parkinson disease","volume":"71","author":"Breen","year":"2014","journal-title":"JAMA Neurol"},{"key":"2024111108300550000_91.7.740.23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygcen.2017.05.013","article-title":"Synchronizing effects of melatonin on diurnal and circadian rhythms","volume":"258","author":"Pfeffer","year":"2018","journal-title":"Gen Comp Endocrinol"},{"key":"2024111108300550000_91.7.740.24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/1567205011666140302195648","article-title":"Rivastigmine for refractory REM behavior disorder in mild cognitive impairment","volume":"11","author":"Brunetti","year":"2014","journal-title":"Curr Alzheimer Res"},{"key":"2024111108300550000_91.7.740.25","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24909"},{"key":"2024111108300550000_91.7.740.26","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/gps.2506","article-title":"The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia","volume":"25","author":"Larsson","year":"2010","journal-title":"Int J Geriatr Psychiatry"},{"key":"2024111108300550000_91.7.740.27","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.6.870"},{"key":"2024111108300550000_91.7.740.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-8343(03)00003-3"},{"key":"2024111108300550000_91.7.740.29","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000233926.47469.73"},{"key":"2024111108300550000_91.7.740.30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1620\/tjem.226.177","article-title":"Effectiveness of pramipexole, a dopamine agonist, on rapid eye movement sleep behavior disorder","volume":"226","author":"Sasai","year":"2012","journal-title":"Tohoku J Exp Med"},{"key":"2024111108300550000_91.7.740.31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/jamaneurol.2015.2904","article-title":"A case of rapid eye movement sleep behavior disorder in Parkinson disease treated with sodium oxybate","volume":"73","author":"Liebenthal","year":"2016","journal-title":"JAMA Neurol"},{"key":"2024111108300550000_91.7.740.32","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.2062","article-title":"Factors hampering the discovery of new therapeutics for rapid eye movement sleep behavior disorder","volume":"76","author":"During","year":"2019","journal-title":"JAMA Neurol"},{"key":"2024111108300550000_91.7.740.33","unstructured":"American Academy of Sleep Medicne . The International classification of sleep disorders. 3rd edn. Westchester, IL: American Academy of Sleep Medicne, 2014."},{"key":"2024111108300550000_91.7.740.34","doi-asserted-by":"crossref","unstructured":"The American Psychiatric Association . Diagnostic and statistical mannaul of mental disorders. 5th edn, 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"2024111108300550000_91.7.740.35","unstructured":"American Academy of Sleep Medicne . The AASM mannual for the scoring of sleep and associated events, 2018."},{"key":"2024111108300550000_91.7.740.36","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24385"},{"key":"2024111108300550000_91.7.740.37","doi-asserted-by":"crossref","first-page":"1104-13","DOI":"10.1212\/WNL.0000000000001364","article-title":"Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials","volume":"84","author":"Postuma","year":"2015","journal-title":"Neurology"},{"key":"2024111108300550000_91.7.740.38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089741"},{"key":"2024111108300550000_91.7.740.39","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.parkreldis.2013.02.009","article-title":"Longitudinal assessment of olfactory function in idiopathic REM sleep behavior disorder","volume":"19","author":"Iranzo","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"2024111108300550000_91.7.740.40","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26431"},{"key":"2024111108300550000_91.7.740.41","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21680"},{"key":"2024111108300550000_91.7.740.42","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.5665\/sleep.3050","article-title":"Cognitive performances and mild cognitive impairment in idiopathic rapid eye movement sleep behavior disorder: results of a longitudinal follow-up study","volume":"36","author":"Terzaghi","year":"2013","journal-title":"Sleep"},{"key":"2024111108300550000_91.7.740.43","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws093"},{"key":"2024111108300550000_91.7.740.44","doi-asserted-by":"crossref","unstructured":"Barber TR , Lawton M , Rolinski M , et al . Prodromal parkinsonism and neurodegenerative risk stratification in REM sleep behavior disorder. Sleep 2017;40.doi:10.1093\/sleep\/zsx071","DOI":"10.1093\/sleep\/zsx071"},{"key":"2024111108300550000_91.7.740.45","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1007\/s00415-014-7317-8","article-title":"Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case\u2013control study","volume":"261","author":"Ferini-Strambi","year":"2014","journal-title":"J Neurol"},{"key":"2024111108300550000_91.7.740.46","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp244"},{"key":"2024111108300550000_91.7.740.47","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1212\/WNL.0000000000003838","article-title":"Predictive markers for early conversion of iRBD to neurodegenerative synucleinopathy diseases","volume":"88","author":"Li","year":"2017","journal-title":"Neurology"},{"key":"2024111108300550000_91.7.740.48","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70152-1"},{"key":"2024111108300550000_91.7.740.49","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s12031-015-0569-7","article-title":"Parkinson's disease genetic loci in rapid eye movement sleep behavior disorder","volume":"56","author":"Gan-Or","year":"2015","journal-title":"J Mol Neurosci"},{"key":"2024111108300550000_91.7.740.50","article-title":"Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson's disease","author":"Leonard","year":"2019","journal-title":"J Med Genet"},{"key":"2024111108300550000_91.7.740.51","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsx197","article-title":"Prevalence and determinants of rapid eye movement sleep behavior disorder in the general population","volume":"41","author":"Haba-Rubio","year":"2018","journal-title":"Sleep"},{"key":"2024111108300550000_91.7.740.52","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21740"},{"key":"2024111108300550000_91.7.740.53","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/mds.25223","article-title":"Validation of the Innsbruck REM sleep behavior disorder inventory","volume":"27","author":"Frauscher","year":"2012","journal-title":"Mov Disord"},{"key":"2024111108300550000_91.7.740.54","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5664\/jcsm.2670","article-title":"Validation of the Mayo sleep questionnaire to screen for REM sleep behavior disorder in a community-based sample","volume":"9","author":"Boeve","year":"2013","journal-title":"J Clin Sleep Med"},{"key":"2024111108300550000_91.7.740.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2009.06.008"},{"key":"2024111108300550000_91.7.740.56","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25037"},{"key":"2024111108300550000_91.7.740.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2010.12.009"},{"key":"2024111108300550000_91.7.740.58","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/jsr.12544","article-title":"Is there a common motor dysregulation in sleepwalking and REM sleep behaviour disorder?","volume":"26","author":"Haridi","year":"2017","journal-title":"J Sleep Res"},{"key":"2024111108300550000_91.7.740.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2011.01.015"},{"key":"2024111108300550000_91.7.740.60","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/mdc3.12591","article-title":"The REM sleep behavior disorder screening questionnaire is not valid in de novo Parkinson's disease","volume":"5","author":"Halsband","year":"2018","journal-title":"Mov Disord Clin Pract"},{"key":"2024111108300550000_91.7.740.61","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/sleep\/28.8.993","article-title":"Validation of a polysomnographic score for REM sleep behavior disorder","volume":"28","author":"Consens","year":"2005","journal-title":"Sleep"},{"key":"2024111108300550000_91.7.740.62","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneumeth.2018.11.016","article-title":"Validation of a new data-driven automated algorithm for muscular activity detection in REM sleep behavior disorder","volume":"312","author":"Cesari","year":"2019","journal-title":"J Neurosci Methods"},{"key":"2024111108300550000_91.7.740.63","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsy053","article-title":"Screening for idiopathic REM sleep behavior disorder: usefulness of actigraphy","volume":"41","author":"Stefani","year":"2018","journal-title":"Sleep"},{"key":"2024111108300550000_91.7.740.64","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/mds.24997","article-title":"Trial designs used to study neuroprotective therapy in Parkinson's disease","volume":"28","author":"Lang","year":"2013","journal-title":"Mov Disord"},{"key":"2024111108300550000_91.7.740.65","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X04268960"},{"key":"2024111108300550000_91.7.740.66","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10609"},{"key":"2024111108300550000_91.7.740.67","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamaneurol.2014.4524","article-title":"Novel methods and technologies for 21st-century clinical trials: a review","volume":"72","author":"Dorsey","year":"2015","journal-title":"JAMA Neurol"},{"key":"2024111108300550000_91.7.740.68","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318199049e"},{"key":"2024111108300550000_91.7.740.69","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000488893","article-title":"Twenty years after: another case report of melatonin effects on REM sleep behavior disorder, using serial dopamine transporter imaging","volume":"76","author":"Kunz","year":"2017","journal-title":"Neuropsychobiology"},{"key":"2024111108300550000_91.7.740.70","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/mds.26878","article-title":"First-In-Human assessment of PRX002, an anti-\u03b1-synuclein monoclonal antibody, in healthy volunteers","volume":"32","author":"Schenk","year":"2017","journal-title":"Mov Disord"},{"key":"2024111108300550000_91.7.740.71","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2017.10.003"},{"key":"2024111108300550000_91.7.740.72","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1610586114"},{"key":"2024111108300550000_91.7.740.73","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-016-1995-9"},{"key":"2024111108300550000_91.7.740.74","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31820f2d79"},{"key":"2024111108300550000_91.7.740.75","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv184"},{"key":"2024111108300550000_91.7.740.76","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2010.07.004"},{"key":"2024111108300550000_91.7.740.77","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jamaneurol.2016.0022","article-title":"Exploring the association between rosacea and Parkinson disease: a Danish nationwide cohort study","volume":"73","author":"Egeberg","year":"2016","journal-title":"JAMA Neurol"},{"key":"2024111108300550000_91.7.740.78","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.lfs.2017.11.016","article-title":"Melatonin protects against behavioral deficits, dopamine loss and oxidative stress in homocysteine model of Parkinson's disease","volume":"192","author":"Paul","year":"2018","journal-title":"Life Sci"},{"key":"2024111108300550000_91.7.740.79","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/jcph.1008","article-title":"Repeated-Dose oral N-acetylcysteine in Parkinson's disease: pharmacokinetics and effect on brain glutathione and oxidative stress","volume":"58","author":"Coles","year":"2018","journal-title":"J Clin Pharmacol"},{"key":"2024111108300550000_91.7.740.80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061700"},{"key":"2024111108300550000_91.7.740.81","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2013.5593"},{"key":"2024111108300550000_91.7.740.82","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf3934"},{"key":"2024111108300550000_91.7.740.83","doi-asserted-by":"publisher","DOI":"10.1007\/s002210000370"},{"key":"2024111108300550000_91.7.740.84","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.5665\/sleep.5040","article-title":"Sleepiness in idiopathic REM sleep behavior disorder and Parkinson disease","volume":"38","author":"Arnulf","year":"2015","journal-title":"Sleep"},{"key":"2024111108300550000_91.7.740.85","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31585-4"},{"key":"2024111108300550000_91.7.740.86","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/acn3.228","article-title":"GBA mutations are associated with rapid eye movement sleep behavior disorder","volume":"2","author":"Gan-Or","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"2024111108300550000_91.7.740.87","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/ana.25082","article-title":"Does smoking impact dopamine neuronal loss in de novo Parkinson disease?","volume":"82","author":"Lee","year":"2017","journal-title":"Ann Neurol"},{"key":"2024111108300550000_91.7.740.88","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31825dd383"},{"key":"2024111108300550000_91.7.740.89","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23687"},{"key":"2024111108300550000_91.7.740.90","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23884"},{"key":"2024111108300550000_91.7.740.91","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1474-4422(17)30040-6","article-title":"Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial","volume":"16","author":"Andrieu","year":"2017","journal-title":"Lancet Neurol"},{"key":"2024111108300550000_91.7.740.92","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-014-9921-4"},{"key":"2024111108300550000_91.7.740.93","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl347"},{"key":"2024111108300550000_91.7.740.94","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/sleep\/30.8.1026","article-title":"REM sleep behavior disorder in patients with guadeloupean parkinsonism, a tauopathy","volume":"30","author":"De Cock","year":"2007","journal-title":"Sleep"},{"key":"2024111108300550000_91.7.740.95","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/mds.27667","article-title":"Yerba mate (Ilex paraguariensis) favors survival and growth of dopaminergic neurons in culture","volume":"34","author":"Bernardi","year":"2019","journal-title":"Mov Disord"},{"key":"2024111108300550000_91.7.740.96","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jns.2015.06.043","article-title":"Inverse association between yerba mate consumption and idiopathic Parkinson's disease. A case-control study","volume":"356","author":"Gatto","year":"2015","journal-title":"J Neurol Sci"},{"key":"2024111108300550000_91.7.740.97","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrneurol.2017.128","article-title":"Long-term effects of exercise and physical therapy in people with Parkinson disease","volume":"13","author":"Mak","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"2024111108300550000_91.7.740.98","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsz064","article-title":"Neuroprotection in idiopathic REM sleep behavior disorder: a role for exercise?","volume":"42","author":"McCarter","year":"2019","journal-title":"Sleep"},{"key":"2024111108300550000_91.7.740.99","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.apmr.2017.08.468","article-title":"Link between Parkinson disease and rapid eye movement sleep behavior disorder with dream enactment: possible implications for early rehabilitation","volume":"99","author":"Johnson","year":"2018","journal-title":"Arch Phys Med Rehabil"},{"key":"2024111108300550000_91.7.740.100","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ana.25026","article-title":"Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder","volume":"82","author":"Iranzo","year":"2017","journal-title":"Ann Neurol"},{"key":"2024111108300550000_91.7.740.101","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.smrv.2018.04.001","article-title":"Presynaptic dopaminergic neuroimaging in REM sleep behavior disorder: a systematic review and meta-analysis","volume":"41","author":"Bauckneht","year":"2018","journal-title":"Sleep Med Rev"},{"key":"2024111108300550000_91.7.740.102","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1212\/WNL.0b013e3182a4a408","article-title":"Increased REM sleep without atonia in Parkinson disease with freezing of gait","volume":"81","author":"Videnovic","year":"2013","journal-title":"Neurology"},{"key":"2024111108300550000_91.7.740.103","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/mds.26665","article-title":"Subliminal gait initiation deficits in rapid eye movement sleep behavior disorder: a harbinger of freezing of gait?","volume":"31","author":"Alibiglou","year":"2016","journal-title":"Mov Disord"},{"key":"2024111108300550000_91.7.740.104","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181ca0166"},{"key":"2024111108300550000_91.7.740.105","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.7.1371"},{"key":"2024111108300550000_91.7.740.106","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/sleep\/31.6.853","article-title":"Elevated Pem (phasic electromyographic metric) rates identify rapid eye movement behavior disorder patients on nights without behavioral abnormalities","volume":"31","author":"Bliwise","year":"2008","journal-title":"Sleep"},{"key":"2024111108300550000_91.7.740.107","doi-asserted-by":"crossref","first-page":"551","DOI":"10.5664\/jcsm.27988","article-title":"Night-to-night variability of muscle tone, movements, and vocalizations in patients with REM sleep behavior disorder","volume":"6","author":"Cygan","year":"2010","journal-title":"J Clin Sleep Med"},{"key":"2024111108300550000_91.7.740.108","doi-asserted-by":"publisher","DOI":"10.5665\/sleep.1886"},{"key":"2024111108300550000_91.7.740.109","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.5665\/sleep.4074","article-title":"Diagnostic thresholds for quantitative REM sleep phasic burst duration, phasic and tonic muscle activity, and REM atonia index in REM sleep behavior disorder with and without comorbid obstructive sleep apnea","volume":"37","author":"McCarter","year":"2014","journal-title":"Sleep"},{"key":"2024111108300550000_91.7.740.110","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/sleep\/30.12.1771","article-title":"EMG variance during polysomnography as an assessment for REM sleep behavior disorder","volume":"30","author":"Burns","year":"2007","journal-title":"Sleep"},{"key":"2024111108300550000_91.7.740.111","doi-asserted-by":"publisher","DOI":"10.1097\/WNP.0b013e318162acd7"},{"key":"2024111108300550000_91.7.740.112","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.sleep.2013.12.022","article-title":"Comparison between an automatic and a visual scoring method of the chin muscle tone during rapid eye movement sleep","volume":"15","author":"Ferri","year":"2014","journal-title":"Sleep Med"},{"key":"2024111108300550000_91.7.740.113","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.5665\/sleep.4076","article-title":"Validation of an integrated software for the detection of rapid eye movement sleep behavior disorder","volume":"37","author":"Frauscher","year":"2014","journal-title":"Sleep"},{"key":"2024111108300550000_91.7.740.114","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2147\/NSS.S189167","article-title":"Comparison of EMG power during sleep from the submental and frontalis muscles","volume":"10","author":"Levendowski","year":"2018","journal-title":"Nat Sci Sleep"},{"key":"2024111108300550000_91.7.740.115","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsy133","article-title":"Comparison of computerized methods for rapid eye movement sleep without atonia detection","volume":"41","author":"Cesari","year":"2018","journal-title":"Sleep"},{"key":"2024111108300550000_91.7.740.116","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1212\/WNL.0000000000004121","article-title":"Characterization of patients with longstanding idiopathic REM sleep behavior disorder","volume":"89","author":"Iranzo","year":"2017","journal-title":"Neurology"},{"key":"2024111108300550000_91.7.740.117","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000960"},{"key":"2024111108300550000_91.7.740.118","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-018-0073-1","article-title":"Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder","volume":"5","author":"Chahine","year":"2019","journal-title":"NPJ Parkinsons Dis"},{"key":"2024111108300550000_91.7.740.119","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00401-017-1684-z","article-title":"Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease","volume":"133","author":"Doppler","year":"2017","journal-title":"Acta Neuropathol"},{"key":"2024111108300550000_91.7.740.120","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1212\/WNL.0000000000003989","article-title":"Skin nerve phosphorylated \u03b1-synuclein deposits in idiopathic REM sleep behavior disorder","volume":"88","author":"Antelmi","year":"2017","journal-title":"Neurology"},{"key":"2024111108300550000_91.7.740.121","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S1474-4422(16)00080-6","article-title":"Assessment of \u03b1-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study","volume":"15","author":"Vilas","year":"2016","journal-title":"Lancet Neurol"},{"key":"2024111108300550000_91.7.740.122","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1212\/WNL.0000000000002126","article-title":"Enteric nervous system \u03b1-synuclein immunoreactivity in idiopathic REM sleep behavior disorder","volume":"85","author":"Sprenger","year":"2015","journal-title":"Neurology"},{"key":"2024111108300550000_91.7.740.123","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.parkreldis.2017.08.002","article-title":"Seven Tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder","volume":"43","author":"Frosini","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"2024111108300550000_91.7.740.124","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/mds.26055","article-title":"Five-Year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder","volume":"29","author":"Iranzo","year":"2014","journal-title":"Mov Disord"},{"key":"2024111108300550000_91.7.740.125","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu290"},{"key":"2024111108300550000_91.7.740.126","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000130"},{"key":"2024111108300550000_91.7.740.127","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/sleep\/31.5.717","article-title":"123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder","volume":"31","author":"Miyamoto","year":"2008","journal-title":"Sleep"},{"key":"2024111108300550000_91.7.740.128","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2016.06.006"},{"key":"2024111108300550000_91.7.740.129","doi-asserted-by":"crossref","first-page":"1724-1733","DOI":"10.1002\/mds.111","article-title":"\u03b1-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies","volume":"33","author":"van Steenoven","year":"2018","journal-title":"Mov Disord"},{"key":"2024111108300550000_91.7.740.130","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/acn3.338","article-title":"Alpha-Synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies","volume":"3","author":"Fairfoul","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"2024111108300550000_91.7.740.131","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-018-0129-5","article-title":"CSF A\u03b21-42 level is associated with cognitive decline in early Parkinson's disease with rapid eye movement sleep behavior disorder","volume":"7","author":"Ba","year":"2018","journal-title":"Transl Neurodegener"},{"key":"2024111108300550000_91.7.740.132","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-014-1314-y"},{"key":"2024111108300550000_91.7.740.133","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.06.008"},{"key":"2024111108300550000_91.7.740.134","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5664\/jcsm.28044","article-title":"Intraindividual variability of REM sleep behavior disorder in Parkinson's disease: a comparative assessment using a new REM Sleep Behavior Disorder Severity Scale (RBDSS) for clinical routine","volume":"7","author":"Sixel-D\u00f6ring","year":"2011","journal-title":"J Clin Sleep Med"},{"key":"2024111108300550000_91.7.740.135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.sleep.2012.09.009","article-title":"An observational clinical and video-polysomnographic study of the effects of clonazepam in REM sleep behavior disorder","volume":"14","author":"Ferri","year":"2013","journal-title":"Sleep Med"},{"key":"2024111108300550000_91.7.740.136","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.5664\/jcsm.6200","article-title":"Effects of rotigotine on REM sleep behavior disorder in Parkinson disease","volume":"12","author":"Wang","year":"2016","journal-title":"J Clin Sleep Med"},{"key":"2024111108300550000_91.7.740.137","doi-asserted-by":"crossref","first-page":"689","DOI":"10.5664\/jcsm.5796","article-title":"An open-labeled trial of Ramelteon in idiopathic rapid eye movement sleep behavior disorder","volume":"12","author":"Esaki","year":"2016","journal-title":"J Clin Sleep Med"},{"key":"2024111108300550000_91.7.740.138","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2377-14-76","article-title":"Actigraphy as a diagnostic aid for REM sleep behavior disorder in Parkinson's disease","volume":"14","author":"Louter","year":"2014","journal-title":"BMC Neurol"},{"key":"2024111108300550000_91.7.740.139","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/mdc3.12813","article-title":"Prognostic counseling for patients with Idiopathic\/Isolated rapid eye movement sleep behavior disorder: should we tell them what's coming? No","volume":"6","author":"Sixel-D\u00f6ring","year":"2019","journal-title":"Mov Disord Clin Pract"},{"key":"2024111108300550000_91.7.740.140","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/mdc3.12814","article-title":"Prognostic counseling for patients with Idiopathic\/Isolated REM sleep behavior disorder: should we tell them what's coming? Yes","volume":"6","author":"St Louis","year":"2019","journal-title":"Mov Disord Clin Pract"},{"key":"2024111108300550000_91.7.740.141","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.sleep.2019.03.010","article-title":"Physician and patient determinants of prognostic counseling in idiopathic REM sleep-behavior disorder","volume":"62","author":"Feinstein","year":"2019","journal-title":"Sleep Med"},{"key":"2024111108300550000_91.7.740.142","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27360"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2020-322875","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T11:30:47Z","timestamp":1731324647000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2020-322875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":142,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,6,18]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1136\/jnnp-2020-322875"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2020-322875","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,13]]}}}